Table 1 Characteristics of patients with interstitial lung diseases (n = 111)
From: Determinants of cough-related quality of life in interstitial lung diseases
Measured variable | |
|---|---|
Age (years) | 67.0 (61.0–73.0) |
Gender (male) | 68 (61.3%) |
BMI (kg/m2) | 28.1 (26.4–31.1) |
Current smoker | 13 (11.7%) |
Ever smoker | 67 (60.4%) |
FVC (% predicted) | 80.0 (72.0–89.0) |
FEV1 (% predicted) | 83.0 (73.0–91.0) |
DLCO (% predicted) (n = 110) | 63.0 (51.4–73.0) |
BAL total cell count (n = 83) | 98.0 (66.0–160.0) |
LCQ total score (n = 110) | 16.8 (13.3–18.7) |
SGRQ total score (n = 99) | 31.4 (16.4–44.0) |
Radiological findings | |
Ground-glass opacity* | 3.0 (0.5–6.0) |
Honeycombing* | 0.0 (0.0–1.0) |
Reticulation* | 9.5 (7.0–11.0) |
Traction bronchiectasis* | 0 (0–0.5) |
Emphysema* | 3.0 (1.5–5.0) |
Precense of histological findings | |
Fibroblast foci | 84 (75.7%) |
Granulomas | 8 (7.2%) |
Giant cells | 13 (11.7%) |
Fibrosis | 105 (94.6%) |
Honeycombing | 31 (27.9%) |
Diagnoses of multidisciplinary discussion | |
Idiopathic pulmonary fibrosis | 70 (63.1%) |
Non-specific interstitial pneumonia | 14 (12.6%) |
Hypersensitivity pneumonitis | 11 (9.9%) |
Sarcoidosis | 3 (2.7%) |
CTD-ILD | 1 |
Asbestosis | 1 |
RB-ILD | 1 |
COP | 1 |
Unclassified fibrosis | 7 (6.3%) |
Other | 2 |
Patient reported chronic cough comorbidities | |
Asthma | 17 (15.3%) |
GERD | 11 (9.9%) |
Chronic rhinosinusitis | 1 |
ACE inhibitor use (n = 110) | 14 (12.7%) |
ILD-GAP index (n = 110) | |
0–1 | 37 (33.6%) |
2–3 | 58 (52.7%) |
4–5 | 15 (13.6%) |
>5 | 0 |